Patient suspected susceptibility to malignant hyperthermia: impact of the disease
Gislene Rodrigues, Pamela Vieira Andrade, Joilson Moura dos Santos, Isac de Castro, José Luiz Gomes do Amaral, Helga Cristina Almeida da Silva
Malignant Hyperthermia (MH) is an inherited hypermetabolic syndrome triggered by exposure to halogenated anesthetics/succinylcholine. The lack of knowledge regarding this condition might be associated with the rare occurrence of MH reaction and symptoms.
This observational study evaluated 68 patients from 48 families with confirmed or suspected MH susceptibility due to medical history of MH reaction or idiopathic increase of creatine kinase or MH-related myopathies. Participants were assessed by a standardized questionnaire and submitted to physical/neurological examination to assess the characteristics of patients with MH, their knowledge about the disease, and the impact suspected MH had on their daily lives.
Suspected MH impacted the daily life of 50% of patients, creating difficulties in performing surgical/clinical/dental treatment and problems related to their family life/working/practicing sports. The questionnaire on MH revealed a correct answer score of 62.1 ± 20.8 (mean ± standard deviation) on a scale 0 to 100. Abnormal physical/neurological examination findings were detected in 92.6% of susceptible patients.
Suspected MH had impacted the daily lives of most patients, with patients reporting problems even before MH investigation with IVCT. Patients showed a moderate level of knowledge about MH, suggesting the need to implement continuing education programs. MH susceptible patients require regular follow-up by a health team to detect abnormalities during physical and neurological examination.
1 RS Litman, SM Griggs, JJ Dowling, et al. Malignant hyperthermia susceptibility and related diseases Anesthesiology, 128 (2018), pp. 159-167
2 Rosenberg H, Sambuughin N, Riazi S, et al. Malignant hyperthermia susceptibility. 2020. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993‒2020. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK1146/).
3 N Monnier, R Krivosic-Horber, JF Payen, et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility Anesthesiology, 97 (2002), pp. 1067-1074
4 JM Santos, PV Andrade, L Galleni, et al. Idiopathic hyperCKemia and malignant hyperthermia susceptibility Can J Anaesth, 64 (2017), pp. 1202-1210
5 MG1 Larach, AR Localio, GC Allen, et al. A clinical grading scale to predict malignant hyperthermia susceptibility Anesthesiology, 80 (1994), pp. 771-779
6 H Vannucchi, MRDL De Unamuno, JS. Marchini Evaluation of nutritional status Medicina (Ribeirão Preto)., 29 (1996), pp. 5-18
7 G Islander, K Rydenfelt, E Ranklev, et al. Male preponderance of patients testing positive for malignant hyperthermia susceptibility Acta Anaesthesiol Scand, 51 (2007), pp. 614-620
8 RS Pinheiro, F Viacava, C Travassos, et al. Gender, morbidity, access and use of health services in Brazil Ciênc Saúde Coletiva, 07 (2002), p. 04,687-707
9 HCA Silva, CS Almeida, JCM Brandão, et al. Malignant hyperthermia in brazil: analysis of hotline activity in 2009 Rev Bras Anestesiol, 63 (2013), pp. 13-19
10 MI Schmidt, BB Duncan, G Azevedo e Silva, et al. Chronic non-communicable diseases in Brazil: Burden and current challenges Lancet, 377 (2011), pp. 1949-1961
11 R Sichieri, J Baima, T Marante, et al. Low prevalence of hypothyroidism among black and mulatto people in a population-based study of Brazilian women Clin Endocrinol, 66 (2007), pp. 803-807
12 AJ Fellet, AF Afonso, Barbosa LF. Osteoartrose/Osteoarthrosis Rev Bras Med, 64 (2007), pp. 55-61
13 Cutrer FM, Moskowitz MA. Cefaleias e outras dores de cabeça. In: Ausiello D, Goldman L. Cecil: Tratado de Medicina Interna. 22ª ed. Rio de Janeiro: Elsevier; 2005, p. 2306-12.
14 LK Arruda, JML Melo the allergy epidemics: why are allergies increasing in Brazil and worldwide? Braz J Allergy Immunol, 3 (2015), pp. 1-6
15 Instituto Brasileiro de Geografia e Estatística IBGE. Pesquisa nacional por amostra de domicílios (online). (citado em 20 jan 2015) Disponível em: http://www.ibge.gov.br/home/estatística/populacao/trabalhoerendimento.
16 APS Ferreira, CL Szwarcwald, GN. Damacena Prevalência e fatores associados da obesidade na população brasileira: estudo com dados aferidos da Pesquisa Nacional de Saúde, 2013 Rev Bras Epidemiol, 22 (2019), Article E190024
17 ER Tammineni, N Kraeva, L Figueroa, et al. Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes Elife, 9 (2020), p. e53999
18 GS Gericke, H. Isaacs An association between certain congenital abnormalities and the malignant hyperthermia trait S Afr Med J, 77 (1990), pp. 570-574
19 MG Larach, BW Brandom, GC Allen, et al. Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States Anesthesiology, 108 (2008), pp. 603-611
20 CM Simões, GN Koishi, M Rozatti, et al. Are we prepared to diagnose and handle an episode of malignant hyperthermia? Rev Bras.Anestesiol, 53 (2003), pp. 248-257